October 6, 2022

Equity Analysis

What Is Driving The Provention Bio (PRVB) Stock Higher Today?

A collaboration deal led Provention Bio Inc.’s stock to gain 22.61% in Thursday’s trading session to $6.07. PRVB stock closed the last trading session at $4.95. PRVB has entered into what kind of collaboration? In order to launch its lead investigational drug candidate, teplizumab, Provention

The DBT News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.